The Radiology Business Journal (11/8, Walter) provides coverage of a new analysis exploring both the benefits and risks of undergoing screening mammography when women turn 75. According to the article, the authors of the analysis conclude that “women should not stop undergoing regular mammography based on their age alone.” They wrote, “Older women are a vulnerable population at risk of developing and dying from breast cancer; however, screening mammography remains underutilized in these women.” One author pointed out “that imaging societies have varying opinions on this issue.” For example, both the Society of Breast Imaging and the American College of Radiology do “not recommend stopping screening on the basis of age.” The findings were published in the American Journal of Roentgenology
HealthDay (11/6, Preidt) reports that a survey suggests “many breast cancer patients skip recommended treatment after surgery because they lack faith in the health care system.” The “survey found those who reported a general distrust of medical institutions and insurers were more likely to forgo follow-up breast cancer treatment, such as chemotherapy, hormone therapy or radiation.” Meanwhile, “trust or distrust of their own doctors did not emerge as a factor.” The findings were published in Cancer Epidemiology, Biomarkers & Prevention.
The Radiology Business Journal (11/6, Walter) reports that research suggests “developing electronic triggers to detect delays in follow-up of abnormal mammographic results offers healthcare providers with an ‘unprecedented opportunity to improve care.’” The findings were published in the Journal of the American College of Radiology.
Medscape (11/3, Nelson) reported that “last year, the French Minister for Health requested that the French National Cancer Institute organize a broad public and scientific consultation on breast cancer screening.” Although it is “still a work in progress, the subsequent report [pdf] issued in April 2017 called for multiple reforms and could be the beginning of a more personalized approach to breast cancer screening.” Medscape added, “In a Viewpoint article published online...in JAMA Internal Medicine, three experts summarize the reforms and offer some insight on how they differ from efforts in other countries.”